LATEST SCIENCE | Quantum Mechanics for Organic Chemists | eBook second edition |
|
|
|
|
|
Quantum Mechanics and Molecular Orbital Theory in particular enables us to understand organic reactions at a deeper level. It is a powerful retrospective analysis tool for computational chemists. Building upon our retrospective analyses of chemistry with Quantum Mechanics, we have successfully incorporated these calculations into our daily prospective retrosynthetic analyses. This second edition of our eBook collated the first twenty four articles which focus on parameters that are useful in correlating chemical reactivity with reaction mechanisms of interest. |
|
|
|
|
WuXi AppTec Scientists have been presented their latest achievements at AACR 2021 |
|
|
|
WuXi AppTec & BaseLaunch - A partnership to jumpstart the launch of early-stage startups
|
|
|
|
|
|
As a Domain Partner, WuXi AppTec supports up-and-coming enterprises in the BaseLaunch portfolio in the discovery and development of future therapeutics. WuXi AppTec leverages comprehensive discovery and technology platforms to evaluate any drug modality, from small molecules and antibodies, to bi-functional molecules (PROTACs) and cell and gene therapies. |
|
|
|
Join our Symposium on Novel Computational Approaches for Hit Generation |
|
|
|
|
|
|
New developments in computational chemistry have led to the creation of ultra-large virtual libraries of compounds while new in silico screening approaches are enabling project teams to explore this vast chemistry space to identify novel hits. Join this three-day symposium to explore these latest technologies and how virtual hits are transferred from virtual to reality.
|
|
|
|
Hear from and engage with leading experts in their fields across top companies including Schrodinger, BioSolveIT, Rectify Pharmaceutical and more. The symposium will feature interactive round table discussions and topics will include:
- Designing, building and searching ultra-large virtual libraries
- In silico high throughput screening utilizing the latest modelling and cloud based approaches
- Converting virtual hits to reality
|
|
|
|
Pharma and Biotech companies are increasingly developing and applying innovative capabilities to make better molecules faster. Many enabling chemistries and technologies have been developed to improve the access to target molecules with expanded chemical diversity. Parallel medicinal chemistry (PMC) is a way to use the advantages of combinatorial chemistry in a manner that provides a more focused approach to target molecules. This results in a more concentrated set of compounds, making the process of lead selection easier.
PMC can shorten the turnaround time of the design-synthesis-test cycle, and it can provide more compounds with limited scaffolds by using streamlined workflows and accumulated parallel synthesis knowledge. New technologies in catalyst/kit screening, photoredox, microscale synthesis, and purification technology are applied in PMC to enhance the speed, diversity and novelty of the compounds for testing.
|
|
|
|
Join this webinar to:
- learn more about recent advances in parallel medicinal chemistry.
- review case studies that highlight effective applications of PMC to accelerate the process of lead candidate selection.
|
|
|
|
|
|
MIXiii-BIOMED 2021 - Israeli Life Science & Technology Week
Meet with Nick Foster, Director, Research Service Division at our virtual booth to discuss your projects and learn more about our platforms.
|
|
|
|
|
|
|
Drug Discovery Chemistry
Our scientists are excited to showcase their novel research during DDC 2021 with the following presentations:
-
Dave Madge, Vice President, Research Service Division “Discovery and characterization of bifunctional degrader molecules”
-
Michael Raba, Program Director “Fragment Screening and Biophysical Hit Validation”
-
Alex Satz, Senior Dir. Strategy & Operations “Discovery of Covalent Inhibitors from DNA-Encoded Libraries”
Attend our presentations, and visit our virtual exhibition to get your urgent drug discovery questions answered by our experienced scientists.
|
|
|
|
|
|
|
Oncolytic Viruses Symposium
Have an oncology question or project you’d like to discuss? Meet with Dave Madge, Vice President, Research Service Division and learn more about our services and solutions.
|
|
|
|
|
|
|
Medicinal Chemistry & Biology - Proventa
Join us for the Strategy Meeting West Coast, where WuXi AppTec Scientists will share their expertise and latest achievements.
-
John Wai, Vice President of Medicinal Chemistry | Keynote: “Integrating Practical AI and Quantum Mechanics tools to synthesis in Medicinal Chemistry”
-
Letian Kuai, Exec. Dir. Head of Strategy & Technology | Roundtable participant, “Opportunities and challenges in discovering novel chemical entities with DNA-Encoded Library (discovery chemistry)”
-
Qunsheng Ji, Vice President, Head of Oncology and Immunology Unit | Roundtable participant, “Target Discovery, Identification and Validation”
-
Henry Lu, Vice President, Head of Biology | Roundtable participant, "In-vitro and in-vivo platform to support COVID preclinical research”
|
|
|
|
|
|
|
AngloNordic Life Science Conference
Meet Nan Zhao, EU Business Development Manager and Rosie Hutchings, Executive Director, Research Service Division during this event to learn more about our innovative platforms.
Please join our experts who will be presenting the WuXi AppTec Hit Finding Platform during a digital workshop.
|
|
|
|
|
|
|
